Krawczyk , P. (2013). Role of molecular examinations in qualification to first line treatment with erlotinib in NSCLC patients based on EUTARCstudy results. OncoReview, 3(1(9), 26-33. Retrieved from https://journalsmededu.pl/index.php/OncoReview/article/view/332